1. Pendlebury, ST, Rothwell, PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 2009; 8: 1006–1018.
Google Scholar | Crossref | Medline | ISI2. Pollock, A, St George, B, Fenton, M, et al. Top ten research priorities relating to life after stroke. Lancet Neurol 2012; 11: 209.
Google Scholar | Crossref | Medline | ISI3. Wardlaw, JM, Doubal, F, Brown, R, et al. Rates risks and routes to reduce vascular dementia (R4vad), a UK-wide multicentre prospective observational cohort study of cognition after stroke: protocol. Eur Stroke J 2020; 6: 128–135.
Google Scholar4. The European Stroke Organisation . The European Stroke Organisation Guidelines: a standard operating procedure. Eur Stroke J 2015; 10: 89–101.
Google Scholar5. Mijajlovic, MD, Pavlovic, A, Brainin, M, et al. Post-stroke dementia – a comprehensive review. BMC Med 2017; 15: 11.
Google Scholar | Crossref | Medline6. Brainin, M, Tuomilehto, J, Heiss, WD, et al. Post-stroke cognitive decline: an update and perspectives for clinical research. Eur J Neurol 2015; 22: 229–236.
Google Scholar | Crossref | Medline | ISI7. Schünemann, H, Brożek, J, Guyatt, G, et al. (eds). GRADE handbook for grading quality of evidence and strength of recommendations. The GRADE Working Group; 2013. Updated October 2013, Available from guidelinedevelopment 2013.org/handbook. Last accessed June 2021.
Google Scholar8. Higgins, JP, Altman, DG, Gøtzsche, PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928.
Google Scholar | Crossref | Medline9. Harrison, JK, Reid, J, Quinn, TJ, et al. Using quality assessment tools to critically appraise ageing research: a guide for clinicians. Age Ageing 2016; 46: 359–365.
Google Scholar | Crossref10. Matz, K, Teuschl, Y, Firlinger, B, et al. Multidomain lifestyle interventions for the prevention of cognitive decline after ischemic stroke: randomized trial. Stroke 2015; 46(10): 2874–2880.
Google Scholar | Crossref | Medline11. Ihle-Hansen, H, Thommessen, B, Fagerland, MW, et al. Multifactorial vascular risk factor intervention to prevent cognitive impairment after stroke and TIA: a 12-month randomized controlled trial. Int J Stroke 2014; 9(7): 932–938.
Google Scholar | SAGE Journals | ISI12. Cheng, C, Liu, X, Fan, W, et al. Comprehensive rehabilitation training decreases cognitive impairment, anxiety, and depression in poststroke patients: a randomized, controlled study. J Stroke Cerebrovasc Dis 2018; 27(10): 2613–2622.
Google Scholar | Crossref | Medline13. Ihle-Hansen, H, Langhammer, B, Lydersen, S, et al. A physical activity intervention to prevent cognitive decline after stroke: secondary results from the Life After STroke study, an 18-month randomized controlled trial. J Rehabil Med 2019; 51(9): 646–651.
Google Scholar | Crossref | Medline14. Deijle, I., Hemnes, R., Boss, M, et al. A randomised controlled trial of aerobic exercise after transient ischaemic attack or minor stroke to prevent cognitive decline: The moveit study. Eur Stroke J 2018; 3(Suppl 1): 91.
Google Scholar15. Cumming, TB, Tyedin, K, Churilov, L, et al. The effect of physical activity on cognitive function after stroke: a systematic review. Int Psychogeriatr 2012; 24(4): 557–567.
Google Scholar | Crossref | Medline16. Lennon, O, Galvin, R, Smith, K, et al. Lifestyle interventions for secondary disease prevention in stroke and transient ischaemic attack: a systematic review. Eur J Prev Cardiol 2014; 21(8): 1026–1039.
Google Scholar | SAGE Journals | ISI17. Hankey, GJ, Ford, AH, Yi, Q, et al. Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a randomized, placebo-controlled trial and meta-analysis. Stroke 2013; 44: 2232–2239.
Google Scholar | Crossref | Medline | ISI18. Toole, JF, Malinow, MR, Chambless, LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004 Feb 4; 291(5): 565–575.
Google Scholar | Crossref | Medline19. Strong, K, Mathers, C, Bonita, R. Preventing stroke: saving lives around the world. Lancet Neurol 2007; 6: 182–187.
Google Scholar | Crossref | Medline | ISI20. Zheng, H, Wang, Y, Wang, A, et al. The efficacy and safety of nimodipine in acute ischemic stroke patients with mild cognitive impairment: a double-blind, randomized, placebo-controlled trial. Sci Bull 2019; 64(2): 101–107.
Google Scholar | Crossref21. Diener, HC, Sacco, RL, Yusuf, S, et al. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the prevention regimen for effectively avoiding second strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol 2008; 7(10): 875–884.
Google Scholar | Crossref | Medline | ISI22. PROGRESS Collaborative Group . Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358(9287): 1033–1041.
Google Scholar | Crossref | Medline | ISI23. Pearce, LA, McClure, LA, Anderson, DC, et al. Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial. Lancet Neurol 2014; 13(12): 1177–1185.
Google Scholar | Crossref | Medline24. SPS3 investigators . Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. NEJM 2012; 367: 817–825.
Google Scholar | Crossref | Medline | ISI25. Hosomi, N, Nagai, Y, Kohriyama, T, et al. The japan statin treatment against recurrent stroke (J-STARS): A multicenter, randomized, open-label, parallel-group study. EBioMedicine 2015; 2(9): 1071–1078.
Google Scholar | Crossref | Medline26. Bath, PM, Scutt, P, Blackburn, DJ, et al. Intensive versus guideline blood pressure and lipid lowering in patients with previous stroke: main results from the pilot ‘prevention of decline in cognition after stroke trial’ (PODCAST) randomised controlled trial. PLoS One 2017; 12: e0164608.
Google Scholar | Crossref | Medline27. Davison, WJ, Myint, PK, Loke, YK, et al. Can cardiovascular risk management be improved by shared care with general practice to prevent cognitive decline following stroke/TIA? A feasibility randomised controlled trial (SERVED memory). BMC Geriatr 2020; 20: 353.
Google Scholar | Crossref | Medline28. Moll van Charante, EP, Richard, E, Eurelings, LS, et al. Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial. Lancet 2016; 388(10046): 797–805.
Google Scholar | Crossref | Medline29. Ngandu, T, Lehtisalo, J, Solomon, A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 2015; 385(9984): 2255–2263.
Google Scholar | Crossref | Medline | ISI30. Bahar-Fuchs, A, Martyr, A, Goh, AM, et al. Cognitive training for people with mild to moderate dementia. Cochrane Database Syst Rev 2019; 3: CD013069.
Google Scholar | Medline31. Gates, NJ, Rutjes, AW, Di Nisio, M, et al. Computerised cognitive training for 12 or more weeks for maintaining cognitive function in cognitively healthy people in late life. Cochrane Database Syst Rev 2020; 2: CD012277.
Google Scholar | Medline32. van de Ven, RM, Murre, JM, Veltman, DJ, et al. Computer-based cognitive training for executive functions after stroke: a systematic review. Front Hum Neurosci 2016; 10: 150. DOI: 10.3389/fnhum.2016.00150.
Google Scholar | Crossref | Medline33. Gavelin, HM, Lampit, A, Hallock, H, et al. Cognition-oriented treatments for older adults: a systematic overview of systematic reviews. Neuropsychol Rev 2020; 30(2): 167–193.
Google Scholar | Crossref | Medline34. Wang, HX, Jin, Y, Hendrie, HC, et al. Late life leisure activities and risk of cognitive decline. J Gerontol A Biol Sci Med Sci 2013; 68: 205–213.
Google Scholar | Crossref | Medline | ISI35. Lee, ATC, Richards, M, Chan, WC, et al. Association of daily intellectual activities with lower risk of incident dementia among older chinese adults. JAMA Psychiatry 2018; 75: 697–703.
Google Scholar | Crossref | Medline36. Wong, A, Lau, AYL, Lo, E, et al. Relations between recent past leisure activities with risks of dementia and cognitive functions after stroke. PLoS One 2016; 11: e0159952.
Google Scholar | Crossref | Medline37. Drozdowska, BA, Celis-Morales, CA, Lyall, DM, et al. Social engagement after stroke - is it relevant to cognitive function? a cross-sectional analysis of UK Biobank data. AMRC Open Res 2019; 1: 3.
Google Scholar | Crossref38. Backhouse, EV, McHutchison, CA, Cvoro, V, et al. Cognitive ability, education and socioeconomic status in childhood and risk of post-stroke depression in later life: A systematic review and meta-analysis. PLoS One 2018; 13(7): e0200525.
Google Scholar | Crossref | Medline39. Khan, F, Amatya, B, Elmalik, A, et al. An enriched environmental programme during inpatient neuro-rehabilitation: A randomized controlled trial. J Rehabil Med 2016; 48(5): 417–425.
Google Scholar | Crossref | Medline40. Frederiksen, KS, Cooper, C, Frisoni, GB, et al. A European Academy of Neurology guideline on medical management issues in dementia. Eur J Neurol 2020; 27: 1805–1820.
Google Scholar | Crossref | Medline41. Bath, PM, Woodhouse, L, Scutt, P, et al. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial. Lancet 2015; 385: 617–628.
Google Scholar | Crossref | Medline | ISI42. Moonen, JE, Foster-Dingley, JC, de Ruijter, W, et al. Effect of discontinuation of antihypertensive treatment in elderly people on cognitive functioning--the DANTE study leiden: a randomized clinical trial. JAMA Intern Med 2015; 175: 1622–1630.
Google Scholar | Crossref | Medline | ISI43. Jongstra, S, Harrison, JK, Quinn, TJ, et al. Antihypertensive withdrawal for the prevention of cognitive decline. Cochrane Database Syst Rev 2016; 11(11): CD011971.
Google Scholar | Medline44. van Dalen, JW, Moll van Charante, EP, van Gool, WA, et al. Discontinuation of antihypertensive medication, cognitive complaints, and incident dementia. J Am Med Dir Assoc 2019; 20: 1091–e3.
Google Scholar | Crossref | Medline45. Croall, ID, Tozer, D, Khan, B, et al. Effect of standard vs intensive blood pressure control on cerebral blood flow in small vessel disease: the PRESERVE randomized clinical trial. JAMA Neurol 2018; 75: 720–727.
Google Scholar | Crossref | Medline46. McGuinness, B, Cardwell, CR, Passmore, P. Statin withdrawal in people with dementia. Cochrane Database Syst Rev 2016; 9(9): CD012050.
Google Scholar | Medline47. Kutner, JS, Blatchford, PJ, Taylor, DH, et al. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. JAMA Intern Med 2015; 175: 691–700.
Google Scholar | Crossref | Medline | ISI48. Lanctôt, KL, Lindsay, MP, Smith, EE, et al. Canadian Stroke Best Practice Recommendations: mood, Cognition and Fatigue following Stroke, 6th edition update 2019. Int J Stroke 2019; 15: 668–68